Clinical Trials Browser

Phase 1 × Neoplasms, Plasma Cell × Hydroxychloroquine × Clear all

NCT00568880 2020-02-07

Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell